ACE-031 vs CJC-1295

A side-by-side comparison from PeptideSciences101, the open peptide reference.

Overview

ACE-031 and CJC-1295 are both performance & growth peptides, but they differ in mechanism, dosing, and regulatory status.

This page compares ACE-031 and CJC-1295 across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

ACE-031CJC-1295
CategoryPerformance & GrowthPerformance & Growth
Regulatory status (US)Research use onlyResearch use only
Typical dosageResearch only1-2 mg
Frequencyresearchweekly
Reported benefitsSignificant muscle growth, strength gainsIncreased muscle mass, fat loss, improved recovery, better sleep, enhanced bone density
Reported side effectsResearch compound, not for human useWater retention, joint pain, potential insulin resistance with prolonged use

Key differences

Primary use. ACE-031 is categorised under Performance & Growth, while CJC-1295 falls under Performance & Growth. Because they target a similar goal, they are common alternatives to weigh against each other.

Regulatory status. ACE-031: not FDA-approved; treated as a research compound. CJC-1295: not FDA-approved; treated as a research compound.

Dosing. ACE-031 is typically dosed at Research only (research). CJC-1295 is typically dosed at 1-2 mg (weekly).

Can you stack them?

Some protocols combine peptides, but stacking ACE-031 and CJC-1295 has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between ACE-031 and CJC-1295?
ACE-031 and CJC-1295 are both performance & growth peptides, but they differ in mechanism, dosing, and regulatory status. ACE-031 is not FDA-approved; generally classified as a research compound, whereas CJC-1295 is not FDA-approved; generally classified as a research compound.
What is ACE-031 used for?
Myostatin inhibitor.
What is CJC-1295 used for?
Growth hormone, muscle mass, fat loss.
Can you take ACE-031 and CJC-1295 together?
Some users combine peptides within a single protocol, but stacking ACE-031 and CJC-1295 has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
Is ACE-031 or CJC-1295 FDA-approved?
ACE-031 is not FDA-approved; generally classified as a research compound. CJC-1295 is not FDA-approved; generally classified as a research compound.

Read the full articles

  • ACE-031 — full monograph: mechanism, research, dosing & references
  • CJC-1295 — full monograph: mechanism, research, dosing & references

More Performance & Growth comparisons

← All peptide comparisons